# Medtronic Completes $650M SPR Therapeutics Deal, Expanding Implantable and Non-Implantable Neuromodulation Offerings

> ma · REPORTED · 2026-07-16

Medtronic finalized its acquisition of SPR Therapeutics for $650 million, integrating the SPRINT temporary peripheral nerve stimulation system into its neuromodulation division alongside existing permanent spinal cord stimulation implants. The acquisition is intended to broaden patient access across more stages of the chronic pain care continuum.

About Medtronic / SPR Therapeutics: SPR Therapeutics developed the SPRINT PNS System, a percutaneous peripheral nerve stimulation device providing up to 60 days of non-surgical, non-opioid pain relief for patients with chronic and acute pain conditions.

- Company: Medtronic / SPR Therapeutics
- Sector: medical devices
- Primary source: https://zenopa.com/us/news/medtronic-completes-650m-spr-therapeutics-deal

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.